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Response
Dear Editors:
We appreciate Dr. Aksoy's response to our paper and
thespecificdataitprovidesregardingthemethodology
usedinhisstudiestocalculate leukemiaincidence and
toestimatebenzene concentrations towhichhiscohort
ofTurkish shoe, slipper, and handbag workers was ex-
posed. Itiswithout questionthatDr. Aksoy'searlyepi-
demiologic observations of the association between
benzene exposure and leukemia are tobe commended.
The major conclusion ofour review, however, was that
the Aksoy studies, as well as some ofthe other avail-
ablebenzene epidemiologicstudies, are notoptimalfor
risk assessment, due primarily tolimitations in quan-
titative exposure information. Given that individual
exposure history data were not apparently available
for workers in the Aksoy study, it remains our judg-
mentthat itprovides a lessuseful basisforthe estima-
tion ofa dose-response relationship thantheRinsky et
al. study that we selected.
SusAN M. BRETT
JOSEPH V. RODRICKS
ENVIRON Corporation
4350 North Fairfax Drive
Arlington, VA 22203
VERNON M. CHINCHILLI
Medical College of Virginia
Other Factors in Leukemia
Dear Editors:
In their interesting paper "Consistencies and Incon-
sistencies Underlyingthe Quantitative Assessment of
Leukemia Risk from Benzene Exposure," Lamm et al.
(1) discussed the results of our paper concerning the
distribution of the types of leukemia in chronic ben-
zene toxicity. According to Lamm et al., 43 (84%) of51
cases of leukemia in my series with chronic benzene
toxicity had acute myelocytic leukemia (AML)(2). Un-
fortunately, there is an important mistake in this cal-
culation. As canbe seeneasilyfromthe paper concern-
ing51 leukemic shoeworkerswithchronicbenzenetox-
icity, only 20 (39.25%) had AML (2). The remaining
were acute lymphoblastic leukemia, 5 shoeworkers
(9.8%); preleukemia, 7 (13.75%); acute erythroleukemia,
10(19.6%); acute myelomonocytic leukemia, 4(7.85%);
acute monocytic leukemia, 1(1.95%); acute undifferen-
tiated leukemia, 1 (1.95%); and chronic myeloid leuke-
mia, 2 (3.9%). On the other hand, it is a matter offact
that there are significant differences concerning the
distribution ofthe types ofleukemia in several studies
on this hematologic malignancy associated with chronic
benzene exposure. In one group, acute types of leuke-
mia predominate, as seen in Vigliani and Forni (3),
Aksoy et al. (2), Infante et al. (4), and Yin et al. (5)
series. Contrary to these, in series of Tareef et al. (6),
Goguel et al. (7), and Browning, who collected series
from the literature (8), chronic types ofleukemia take
the first place in the series ofleukemia due to chronic
benzene toxicity. Considering the above-mentioned
striking differences, we suggested that these findings
may be partly explained by exposure levels, the mode
ofexposure, andthepresence orabsence ofotherhomo-
logs of benzene such as toluene and xylene or other
chemicals (9).
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Turkey
Response
Dear Editors:
We arepleasedtohearfromthedistinguished Profes-
sor MuzafferAksoy who has contributedgreatly tothe
literature on benzene and leukemia. He has raised a
number of questions concerning our review (1) and
analysis ofthe epidemiological studies ofbenzene and
leukemia. Inourreview, weanalyzedthe setofpublished
population-based studies of leukemia (case count five
or greater) among benzene-exposed workers. We in-
cludedallthestudiesthat(a)indicatedthe sizeanddef-
inition ofthepopulationstudied,(b)commented onthe
characteristics of the benzene exposure, and (c) ap-
peared to have identified all the cases within their
studied population. The second group of studies thatLETTERS TO THE EDITOR 167
Aksoy mentioned did not meet these criteria. Those
studies either reviewedthe literature or analyzed case
series; each lack both a specific study population (or
complete case count) and a measurement of the ben-
zene exposure. Our literature review is complete for
the studies that meet the criteria.
Aksoyhasquestionedour descriptionthat 84% ofhis
reported leukemias (2) in benzene-exposed workers
were acute myeloid leukemias (AML). As discussed in
our paper, we usedthe term "acute myeloidleukemia"
to encompass all the variants ofacute leukemia ofmy-
eloid origin classified by the FAB (French-American-
British Cooperative Group) (3) as the M1 through M7
categories. We thus included in the AML category not
only the myeloblastic leukemias but also the erythro-
leukemias, promyelocytic leukemia, monocytic leuke-
mias, myelo-monocytic leukemias, and would have in-
cluded megakaryoblastic leukemias ifthere had been
any. We also included the group ofpreleukemias (my-
elodysplastic syndrome) which usually terminate as
AML, since Aksoy included them in his list of leuke-
mias. Hadwe notincludedthepreleukemias, we would
have reported that 81% (34/42) of the leukemias re-
ported by Aksoy in benzene-exposed workers were
AML. The only cases in Aksoy's reports that do not be-
long inthe AML category as defined by the FAB group
and described in our paper are the five acute lympho-
blastic leukemia cases, the two chronic myelogenous
leukemia cases, and (possibly) the undifferentiated
leukemia case (where one needs markers ofkaryotype
findings to better ascertain origin).
The observations from Professor Aksoy's study are
consistent with the general observation that it is the
AMLsthatarefoundinexcess amongbenzene-exposed
workers. In 1977, Goldstein (4) had reviewed the
world's literature which included the studies cited by
Aksoy and concluded that only AML and its variants
had been definitely associated with benzene exposure.
We have now extended that observation to the subse-
quentlypublishedepidemiological literature andhave
concluded that it is AML that can be caused by exces-
sive benzene exposure. While individual case reports
and case series have reported chronic leukemias in
benzene-exposed workers, the hypothesis thatthey are
found in excess among benzene-exposed workers is
notsupportedbythedataintheepidemiological litera-
ture. Some previous studies initially indicating an ex-
cess of chronic leukemias among solvent-exposed
workers(wherebenzene hadbeenthe solventofchoice)
(5) have subsequently been found to be related to non-
benzene solvent exposures, such as carbon disulfide
and not to benzene (6). We concur with Professor Ak-
soy's suggestion thatthe other disorders may relate to
nonbenzene exposure (7).
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